Meningiomas: Role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema

Neurosurgery

Volumn 40, Issue 5, 1997, Pages 1016-1026

  Provias, John ^a   Claffey, Kevin ^b   DelAguila, Leslie ^b   Lau, Nelson ^d   Feldkamp, Matthias ^d   Guha, Abhijit ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d NONE

Author keywords

Angiogenesis; Meningioma; Peritumoral edema; Reactive astrocytes; Vascular endothelial growth factor; Vascular permeability factor

Indexed keywords

ANGIOGENIC FACTOR; MESSENGER RNA; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; ASTROCYTOMA; COMPUTER ASSISTED TOMOGRAPHY; EDEMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MENINGIOMA; METASTASIS; MITOGENESIS; NORTHERN BLOTTING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 0030910881     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199705000-00027     Document Type: Article

References (60)

1. Abe T, Black PMcL, Ojemann RG, Hedley-White ET: Cerebral edema in intracranial meningiomas: Evidence for local and diffuse patterns and factors associated with its occurrence. Surg Neurol 42:471-475, 1994.
2. Alvarez JA, Baird A, Tatum A, Daucher J, Chorsky R, Gonzalez A, Stopa E: Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms. Mod Pathol 5:303-307, 1992.
3. 121. Cancer Res 55:5296-5301, 1995.
4. Barelon B, Hauser S, Schollmann C, Weindel K, Marme D, Yayon A, Weich HA: Differential expression of the two VEGF receptors FLT and KDR in placenta and vascular endothelial cells. J Cell Biochem 54:56-66, 1994.
5. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR: Vascular permeability factor (vascular endothelial growth factor) gene is expressed differently in normal tissues, macrophages, and tumors. Mol Biol Cell 3:211-220, 1992.
6. Black PMcL: Meningiomas. Neurosurgery 32:643-657, 1993.
7. Bos JL: ras oncogenes in human cancers: A review. Cancer Res 49:4682-4689, 1989.
8. Bouck N: Tumor angiogenesis: The role of oncogenes and tumor suppressor genes. Cancer Cells 2:179-185, 1990.
9. Breier G, Albrecht U, Sterrer S, Risau W: Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114:521-532, 1992.
10. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 138:213-220, 1991.
11. Brown LF, Berse B, Jackman RW, Tognazzi K, Manseau EJ, Senger DR, Dvorak HF: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 53: 4727-4735, 1993.
12. Brown LF, Berse B, Tognazzi K, Manseau EJ, Van De Water L, Senger DR, Dvorak HF, Rosen S: Vascular permeability factor mRNA and protein expression in human kidney. Kidney Int 42:1457-1461, 1992.
13. Connolly DT: Vascular permeability factor: A unique regulator of blood vessel function. J Cell Biochem 47:219-223, 1991.
14. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Eppley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470-1478, 1989.
15. Criscuolo G, Merrill M, Oldfield E: Further characterization of malignant glioma-derived vascular permeability factor. J Neurosurg 69:254-262, 1988.
16. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The FMS-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255:989-991, 1992.
17. Dvorak HF, Brown LF, Detmar M, Dvorak AM: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039, 1995.
18. Dvorak HF, Sioussat TM, Brown LF, Berse B, Nagy JA, Sotrel A, Manseau EJ, Van De Water L, Senger DR: Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: Concentration in tumor blood vessels. J Exp Med 174: 12750-12780, 1991.
19. Ferrara N, Houck K, Jakeman L, Leung D: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32, 1992.
20. Deleted in proof.
21. Finkenzeller G, Marme D, Weich HA, Hug H: Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Res 52:4821-4823, 1992.
22. Finkenzeller G, Technau A, Marme D: Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional API transcription factor. Biochem Biophys Res Commun 208:432-439, 1995.
23. Folkman J, Shing Y: Angiogenesis. J Biol Chem 267:10931-10934, 1992.
24. Fong G-H, Rossant J, Gertsenstein M, Breitman ML: Role of the FLT-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376:66-70, 1995.
25. 24a. French CC, Van De Water L, Dvorak HF, Ro H: Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 109:903-914, 1989.
26. Goldman CK, Kim J, Wong W-L, King V, Brock T, Gillespie GY: Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: A model of glioblastoma multiforme pathophysiology. Mol Biol Cell 4:121-133, 1993.
27. Guha A, Lau N, Gutmann D, Provias J, Pawson T, Boss G: Ras-GTP levels are elevated in human NFl peripheral nerve tumors. Oncogene 12:507-513, 1996.
28. Hatva E, Kaipainen A, Mentula P, Jaaskelainen J, Paetau A, Haltia M, Alitalo K: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 146:368-378, 1995.
29. Holmgren L, O'Reilly M, Folkman J: Dormancy of micrometastasis: Balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Med 1:149-152, 1995.
30. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW: The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 5:1806-1814, 1991.
31. Jagadha V, Deck J: Massive cerebral edema associated with meningioma. Can J Neurol Sci 14:55-58, 1987.
32. Kim KJ, Li B, Armanini M, Gillett N, Phillips HS, Ferrara N: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362:841-844, 1993.
33. Kohl NE, Mosser SD, deSolms SJ, Giuliani EA, Pompliano DL, Graham SL, Smith RL, Scolnick EM, Oliff A, Gibbs JB: Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor. Science 260:1934-1937, 1993.
34. Leung DW, Cachianes G, Kuang W-K, Goeddel DV, Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1312, 1989.
35. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, Chambon P: Cloning of a ribosome-associated protein cDNA, 36B4. Nucleic Acids 10:7895-7903, 1982.
36. Millauer B, Shawver LK, Plate KH, Risnu W, Ullrich A: Glioblastoma growth inhibited in vivo by a dominant-negative FLK-1 mutant. Nature 367:576-578, 1994.
37. Millauer B, Wizigmann-Voos S, Schnürch H, Martinez R, Møller NPH, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72:835-846, 1993.
38. Mukhopadhyay D, Tsiokas L, Zhou X-M, Foster D, Brugge J, Sukhatme V: Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375: 577-581, 1995.
39. Mulcahy LS, Smith MR, Stacey DW: Requirement for ras protooncogene function during serum-stimulated growth of NIH 3T3 cells. Nature 313:241-243, 1985.
40. Nagasu T, Yoshimatsu K, Rowell C, Lewis M, Garcia A: Inhibition of human tumor xenograft growth by treatment with the farnesyl transferase inhibitor B956. Cancer Res 55:5310-5314, 1995.
41. Plate KH, Breier G, Weich HA, Risau W: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas. Nature 359:845-848, 1992.
42. ras in PC12 cells by distinct, convergent pathways involving tyrosine phosphorylation. Neuron 7:937-946, 1991.
43. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T, Kerbel R: Mutant ras oncogenes up-regulate VEGF/VPF expression: Implications for induction and inhibition of tumor angiogenesis. Cancer Res 55:4575-4580, 1995.
44. Salpietro F, Alafaci C, Lucerno S, Iacopino D, Todaro C, Tomasello F: Peritumoral edema in meningiomas: Microsurgical observations of different brain tumor interfaces related to computed tomography. Neurosurgery 35:638-642, 1994.
45. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, C Fukui M: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 55:1189-1193, 1995.
46. Satoh T, Kaziro Y: Ras in signal transduction. Cancer Biol 3:169-177, 1992.
47. Satoh T, Endo M, Nakafuku M, Akiyama T, Yamamoto T, Kaziro Y: Accumulation of p21 Ras-GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc Natl Acad Sci U S A 87:7926-7929, 1990.
48. ras-GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci USA 87:5993-5997, 1990.
49. Senger DR, Galli SJ, Dvorak AM, Peruzzi CA, Harvey VS, Dvorak HF: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985, 1983.
50. Senger DR, Peruzzi CA, Feder J, Dvorak HF: A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Res 46:5629-5632, 1986.
51. Shalaby F, Rossant J, Yamaguchi T, Gertsenstein M, Wu X-F, Breitman M, Schuh A: Failure of blood island formation and vasculogenesis in Flk-1-deficient mice. Nature 376:62-66, 1995.
52. Shweiki D, Itin A, Soffer D, Keshe E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845, 1992.
53. Sioussat TM, Dvorak HF, Brock TA, Senger DR: Inhibition of vascular permeability factor (vascular endothelial growth factor) with antipeptide antibodies. Arch Biochem Biophys 301:15-20, 1993.
54. Smith D, Cahill D: The biology of meningiomas. Neurosurg Clin North Am 5:201-215, 1994.
55. Strugar J, Rothbart D, Harrington W, Criscuolo G: Vascular permeability factor in brain metastasis: Correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81:560-566, 1994.
56. Terman BI, Dougher-Vermazen M, Carrion ME, Dimitrov D, Armellino DC, Gospodarowicz D, Bohlen P: Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 187:1579-1586, 1992.
57. Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, Abraham JA: The human gene for vascular endothelial growth factor. J Biol Chem 266:11947-11954, 1991.
58. Tsai J-C, Goldman CK, Gillespie GY: Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 82:864-873, 1995.
59. Weindel K, Moringale J, Marme D, Weich H: Detection and quantification of vascular endothelial growth factor/vascular permeability factor in brain tumor tissue and cyst fluid: The key to angiogenesis? Neurosurgery 35:439-449, 1994.
60. Yeo K-T, Wang H, Nagy J, Sioussat T, Ledbetter S, Hoogwerf A, Zhou Y, Masse E, Senger D, Dvorak H, Yeo T-K: Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions. Cancer Res 53:2912-2918, 1993.